Mendelics

Mendelics is a pioneering genetic analysis laboratory headquartered in São Paulo, Brazil, dedicated to revolutionizing medicine by making genomic analysis accessible to everyone. Founded with the mission to democratize genetic testing, the company has established itself as the largest Next-Generation Sequencing (NGS) laboratory in Latin America.

The company offers an extensive portfolio of genetic tests covering multiple medical specialties including Cardiology, Dermatology, Endocrinology, Gastroenterology, Medical Genetics, Hematology, Nephrology, Neurology, Ophthalmology, Oncology, Otolaryngology, and Women's Health. Their flagship product, the Exoma Mendelics, delivers the highest diagnostic rate in the market, while their popular "Teste da Bochechinha" (Cheek Test) screens for over 300 diseases in a single examination.

Mendelics provides genetic testing for hereditary cancer, polygenic risk analysis for breast cancer, carrier screening for recessive diseases, and panel tests for various conditions. The company operates with state-of-the-art laboratory techniques and maintains accreditation and certifications ensuring the highest quality standards. With partnerships across major health insurance providers in Brazil, Mendelics continues to expand access to precision medicine across the country.